» Articles » PMID: 30864011

Vitamin D Deficiency in Adult Patients with Ulcerative Colitis: Prevalence and Relationship with Disease Severity, Extent, and Duration

Overview
Specialty Gastroenterology
Date 2019 Mar 14
PMID 30864011
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D plays a key role in gut immunity and maintenance of the mucosal barrier. Vitamin D deficiency (VDD) worsens ulcerative colitis (UC) and its supplementation ameliorates the disease in mouse models. The prevalence and predictors of VDD in UC are not known.

Methods: Consecutive patients with UC (n = 80) underwent clinical, endoscopic, and histological evaluation to assess the extent, severity using UC disease activity index (UCDAI) score, and duration of illness. An equal number of age and gender-matched healthy adults without any features of inflammatory bowel disease (IBD) living in the same latitude were identified as controls. The serum 25-hydroxy vitamin D level was estimated. The subjects were classified as deficient (< 20 ng/mL), insufficient (20-32 ng/mL), sufficient (32-80 ng/mL), and optimal (> 80 ng/mL) based on vitamin D levels. Chi-square test and Mann-Whitney U test were done to identify factors associated with vitamin D deficiency.

Results: The patients and controls were similar in age and gender (40 ± 11.4 years, 51% male vs. 40 ± 12 years, 51% male; p = 1.000). Median vitamin D levels among patients were lower than the controls (18.1 ng/mL [IQR 14] vs. 32.5 ng/mL [IQR 36]; p < 0.001). Patients were more often VDD (56% vs. 40%) or insufficient (34% vs. 9%) and less often sufficient (9% vs. 40%) or optimal (1% vs. 11%), in contrast to controls (p < 0.001). Median vitamin D levels were lower in those with UCDAI > 6 (15 vs. 21 ng/mL; p = 0.01), having pancolitis (13 vs. 21 ng/mL, p = 0.01), and longer duration of illness > 2 years (13.8 vs. 20.8; p = 0.025). Vitamin D levels showed a negative correlation with frequency of stools (rho = - 0.244, p = 0.05), disease duration (rho = - 0.244, p = 0.007) and UCDAI score (r = - 0.348, p = 0.002).

Conclusion: VDD is highly prevalent among patients with UC. Patients with longer disease duration, more severe symptoms, and pancolitis are likely to have lower vitamin D levels.

Citing Articles

The role of vitamin D in treated and refractory ulcerative colitis patients: a case-control study.

Ahmadi A, Shokoohizadeh L, Sheikhesmaili F, Nikkhoo B, Mohammadi A, Khan Mirzaei M BMC Gastroenterol. 2024; 24(1):454.

PMID: 39695960 PMC: 11653863. DOI: 10.1186/s12876-024-03558-4.


Autophagy and its role in gastrointestinal diseases.

Shao B, Zhang W, Liu Z, Linghu E World J Gastroenterol. 2024; 30(36):4014-4020.

PMID: 39351250 PMC: 11439115. DOI: 10.3748/wjg.v30.i36.4014.


Co-administration of 1,25-dihydroxyvitamin D3 and infliximab improves colitis in mice by modulating Treg differentiation.

Hu Y, Wang Y, Chen Y, Li C, Long Y, Wu C Iran J Basic Med Sci. 2024; 27(9):1172-1179.

PMID: 39055880 PMC: 11266739. DOI: 10.22038/IJBMS.2024.74640.16209.


Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease.

Macias-Ceja D, Barrachina M, Ortiz-Masia D Front Pharmacol. 2023; 14:1170436.

PMID: 37397491 PMC: 10307973. DOI: 10.3389/fphar.2023.1170436.


Influences of Vitamin D and Iron Status on Skeletal Muscle Health: A Narrative Review.

Shoemaker M, Salmon O, Smith C, Duarte-Gardea M, Cramer J Nutrients. 2022; 14(13).

PMID: 35807896 PMC: 9268405. DOI: 10.3390/nu14132717.


References
1.
Veldman C, Cantorna M, DeLuca H . Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000; 374(2):334-8. DOI: 10.1006/abbi.1999.1605. View

2.
Goswami R, Gupta N, Goswami D, Marwaha R, Tandon N, Kochupillai N . Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000; 72(2):472-5. DOI: 10.1093/ajcn/72.2.472. View

3.
Cantorna M, Munsick C, Bemiss C, Mahon B . 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000; 130(11):2648-52. DOI: 10.1093/jn/130.11.2648. View

4.
Papaioannou A, Ferko N, Adachi J . All patients with inflammatory bowel disease should have bone density assessment: pro. Inflamm Bowel Dis. 2001; 7(2):158-62; discussion 168-9. DOI: 10.1097/00054725-200105000-00012. View

5.
DeLuca H, Cantorna M . Vitamin D: its role and uses in immunology. FASEB J. 2001; 15(14):2579-85. DOI: 10.1096/fj.01-0433rev. View